$11.37
Price
$839M
Market Cap
—
P/E Ratio
-8.2
Forward P/E
$-1.41
EPS (TTM)
—
Dividend Yield
$395M
Cash
$109M
Total Debt
65M
Shares Out
$10.95
$27.63
52-Week Range
Institutional Ownership of SCHRODINGER INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Gates Foundation Trust|Michael Larson
|
7.0M | $125M | $43.09 | -59.46% |
Trading Activity for SCHRODINGER INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2020-Q4 | |||||
| BUY | +40.1% | 7.0M | $553M | $58.95 | |
| 2020-Q3 | |||||
| SELL | -28.6% | 5.0M | $237M | $68.68 | |
| 2020-Q2 | |||||
| SELL | +0.0% | 7.0M | $639M | $57.87 | |
| 2020-Q1 | |||||
| BUY | NEW | 7.0M | $301M | $38.55 | |
Insider Trading for SCHRODINGER INC
6 Months Insider Sentiment
Buy $0
Sell $29K
0
Buys
1
Sells
-29K
Net
0
Grants
Largest
$29K
Dugan
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 16, 2025 | Margaret Dugan | Chief Medical Officer | SELL | 1.4K | $21.07 | $29K |